- Navigating new regulations around clinical trials smoothly and successfully
- The impact of artificial intelligence: how far can we expect to move forward in the next 12 months?
- Patient centricity in clinical trials: how can burden be reduced in order to make trials easier for patients to participate in?
- How may geopolitical and geoeconomic events including the financial crisis, the Inflation Reduction Act and the upcoming election impact clinical trials in the US?
- Technological developments into 2025 and beyond: what changes can we expect to see in the next 3-5 years?
MODERATOR: Revati Tatake, Global Head of Pharma Research, Analysis and Competitive Intelligence, GlobalData Healthcare